Dehydrogenation of indoline by cytochrome P450 enzymes: A novel "aromatase" process

被引:34
|
作者
Sun, Hao
Ehlhardt, William J.
Kulanthaivel, Palaniappan
Lanza, Diane L.
Reilly, Christopher A.
Yost, Garold S.
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[2] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
关键词
D O I
10.1124/jpet.107.121723
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Indoline derivatives possess therapeutic potential within a variety of drug candidates. In this study, we found that indoline is aromatized by cytochrome P450 (P450) enzymes to produce indole through a novel dehydrogenation pathway. The indole products can potentially be bioactivated to toxic intermediates through an additional dehydrogenation step. For example, 3-substituted indoles like 3-methylindole and zafirlukast [4-(5-cyclopentyloxy- carbonylamino-1-methyl-indol-3-ylmethyl)-3methoxy-N-o-tolylsulfonylbenzamide] are dehydrogenated to form 3-methyleneindolenine electrophiles, which react with protein and/or DNA nucleophilic residues to cause toxicities. Another potentially significant therapeutic consequence of indoline aromatization is that the product indoles might have dramatically different therapeutic potency than the parent indolines. In this study, indoline was indeed efficiently aromatized by human liver microsomes and by several P450s, but not by flavin-containing monooxygenase (FMO) 3. CYP3A4 had the highest aromatase activity. Four additional indoline metabolites [2,3,4,7-tetrahydro-4,5-epoxy-1H-indole (M1);N-hydroxyindole (M2), N-hydroxyindoline (M3), and M4 ([ 1,4,2,5]dioxadiazino[2,3-a: 5,6-a'] diindole)] were characterized; none was a metabolite of indole. M1 was an arene oxide from P450 oxidation, and M2, M3, and M4 were produced by FMO3. Our data indicated that indoline was oxidized to M3 and then to an intermediate indoline nitrone, which tautomerized to form M2, and subsequently dimerized to a di-indoline. This dimer was immediately oxidized by FMO3 or atmospheric oxygen to the final product, M4. No evidence was found for the P450-mediated production of an aliphatic alcohol from indoline that might dehydrate to produce indole. Therefore, P450 enzymes catalyze the novel "aromatase" metabolism of indoline to produce indole. The aromatase mechanism does not seem to occur through N-oxidation or dehydration of an alcohol but rather through a formal dehydrogenation pathway.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 50 条
  • [41] Aromatase cytochrome P450 enzyme expression in human pituitary
    Pinar Kadioglu
    Gokhan Oral
    Muge Sayitoglu
    Nevin Erensoy
    Berna Senel
    Nurperi Gazioglu
    Aydin Sav
    Gursel Cetin
    Ugur Ozbek
    Pituitary, 2008, 11 : 29 - 35
  • [42] Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes
    Shimada, T
    Mernaugh, RL
    Guengerich, FP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 435 (01) : 207 - 216
  • [43] Discovery and engineering of novel cytochrome P450 enzymes for converting lignin into to chemicals
    不详
    INTERNATIONAL SUGAR JOURNAL, 2018, 120 (1436): : 596 - 597
  • [44] Unlocking the Clinical Significance of Cytochrome P450 Enzymes
    Hadia, Rajesh
    Singh, Vishal
    Solanki, Nidhi
    Sharma, Shiwanand
    Saggu, Varunsingh
    Sajan, Cyril
    Trivedi, Rahul
    Kardani, Sunil
    Baile, Sunil
    Rajput, Hemraj Singh
    Maheshwari, Rajesh
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (01) : 30 - 38
  • [45] Inhibition of Cytochrome P450 Enzymes by Quinones and Anthraquinones
    Sridhar, Jayalakshmi
    Liu, Jiawang
    Foroozesh, Maryam
    Stevens, Cheryl L. Klein
    CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (02) : 357 - 365
  • [46] Cytochrome P450 - Versatile enzymes for medicine and biotechnology
    Urlacher V.B.
    Bernhardt R.
    BIOspektrum, 2019, 25 (7) : 715 - 718
  • [47] Effects of icaritin on cytochrome P450 enzymes in rats
    Liang, Dong-Lou
    Zheng, Shuang-li
    PHARMAZIE, 2014, 69 (04): : 301 - 305
  • [48] Cancer treatment and pharmacogenetics of cytochrome P450 enzymes
    van Schaik, RHN
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (06) : 513 - 522
  • [49] Steroidogenic cytochrome P450 enzymes as drug target
    Kim, Changmin
    Jeong, Eunseo
    Lee, Yoo-bin
    Kim, Donghak
    TOXICOLOGICAL RESEARCH, 2024, 40 (03) : 325 - 333
  • [50] Cytochrome P450 - redox partner fusion enzymes
    Munro, Andrew W.
    Girvan, Hazel M.
    McLean, Kirsty J.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2007, 1770 (03): : 345 - 359